MedPath
NMPA Approval

Remifentanil Hydrochloride for Injection

国药准字H20030199

June 10, 2020

Drug Information

注射用盐酸瑞芬太尼

瑞捷

注射剂

2mg(按C20H28N2O5计)

化学药品

June 10, 2020

Company Information

Applicant Company

湖北省宜昌开发区大连路19号

Manufacturing Company

1.湖北省宜昌开发区大连路19号,2.湖北省宜昌市东临路517号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.